Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | FABP7 | O15540 | 1/20 | 0.34 |
| ▸ | FABP3 | P05413 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12113510 | 0.85 | NPSR1 (0.38) | NPSR1FABP7FABP3FABP5POLB | |
| SCHEMBL14596131 | 0.85 | CA1 (0.39) | NPSR1POLBALDH1A1HTTKMT2A | |
| SCHEMBL12112040 | 0.82 | NPSR1 (0.36) | NPSR1FABP7FABP3FABP5POLB | |
| SCHEMBL14596137 | 0.76 | KMT2A (0.40) | NPSR1POLBALDH1A1HTTKMT2A | |
| SCHEMBL13536496 | 0.76 | NPSR1 (0.36) | NPSR1POLBALDH1A1HTTKMT2A | |
| SCHEMBL14596143 | 0.73 | KMT2A (0.35) | NPSR1POLBALDH1A1HTTKMT2A | |
| SCHEMBL132989 | 0.72 | WDR5 (0.44) | NPSR1POLBALDH1A1HTTKDM4E | |
| SCHEMBL29382484 | 0.72 | WDR5 (0.44) | NPSR1POLBALDH1A1HTTKDM4E | |
| SCHEMBL132985 | 0.70 | NPSR1 (0.44) | NPSR1POLBALDH1A1HTTKMT2A | |
| SCHEMBL14020795 | 0.70 | NPSR1 (0.52) | NPSR1POLBALDH1A1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8053588-B2 | organosilane compounds used as raw materials for synthesis of organosilicon polymer thin films, having a refractive-index controlling function, a light absorbing function, a light emitting function, and a charge transferring function | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20080227939-A1 | Organosilane compound and organosilica obtained therefrom | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227939-A1 | Organosilane compound and organosilica obtained therefrom | CARM1, PRMT1, PRMT8 | NPSR1 724/4885FABP7 3872/4885FABP3 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.